Clinical trial Recruiting at 1 site Observational Ages 18 and up

How end-tidal CO2 changes during a leg raise help predict if fluids will help ICU patients

Official title: The Role of End-Tidal Carbon Dioxide Changes During Passive Leg Raising in Predicting Fluid Responsiveness for Mechanically Ventilated Patients in the Intensive Care Unit: A Prospective Observational Study

Run by Izmir Katip Celebi University · NCT07304648 · Data updated 2026-11-12

This study checks if small increases in exhaled CO2 during a passive leg raise can tell doctors which critically ill, mechanically ventilated patients will respond to a fluid bolus.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment68 (estimated)
SponsorIzmir Katip Celebi University
Academic / other
Locations1 site (Izmir)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJanuary 1, 2027
Study endsJuly 1, 2027
Registry record updatedNovember 4, 2026
Trial IDNCT07304648 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) in the ICU on mechanical ventilation for at least 24 hours who are planned for a mini fluid challenge and have consent via a legal representative.

Probably not a fit

Patients who do not exhibit a Delta EtCO2 response or whose hemodynamics do not change with a mini fluid challenge may not benefit from guidance based on EtCO2 during PLR.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study in the ICU tests whether changes in End-Tidal CO2 during a Passive Leg Raising maneuver can predict fluid responsiveness compared with a Mini Fluid Challenge. Eligible patients are adults on mechanical ventilation who are planned for a fluid bolus and have consent from a legal representative. The study uses EtCO2 delta as a non-invasive surrogate for cardiac output changes, validating results against LVOT-VTI or arterial pressure responses after the mini fluid challenge. It is single-center and focuses on improving fluid-resuscitation decisions to avoid fluid overload. The approach aims to identify a non-invasive, rapid bedside test to guide therapy in circulatory failure.

Why it matters

Potential benefit: If successful, clinicians could more accurately identify which ICU patients will benefit from fluids using a simple, non-invasive measurement.

How similar studies have gone: Previous work supports dynamic tests like PLR, and non-invasive surrogates are being explored, but this exact Delta EtCO2 approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 years or older.
* Patients who have been followed in the intensive care unit (ICU) with mechanical ventilation support for at least 24 hours.
* Patients for whom a mini fluid challenge (MFC) is clinically planned by the intensive care team.
* Patients for whom informed consent has been obtained from first-degree relatives or a legal representative.

Exclusion Criteria:

* Patients younger than 18 years of age.
* Pregnant patients.
* Patients without consent from first-degree relatives or a legal representative.
* Patients with known deep vein thrombosis (DVT) in the leg veins (risk of embolism during leg raising).
* Patients with pathologies that may cause increased intracranial pressure (e.g., intracranial mass, hemorrhage).
* Patients with uncontrolled hypertension.
* Patients with severe cardiac disease (e.g., right heart failure, pulmonary hypertension, advanced valvular pathology).
* Patients with carbon dioxide (CO2) retention.
* Patients who have undergone hip surgery or hip replacement surgery where Passive Leg Raising (PLR) cannot be performed.
* Patients with spontaneous breathing.
* Patients with a probability of high intra-abdominal pressure.
* Patients who cannot lie in a supine position.
* Patients with current peripheral oxygen saturation (SpO2) \< 88%.
* Patients on mechanical ventilation requiring pressure support \> 16 mmHg or PEEP \> 10 mmHg.

Where it's running

  • Izmir Katip Celebi University Atatürk Training and Research Hospital
    Izmir, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Murat Aksun, M.D. — Izmir Katip Celebi University Atatürk Training and Research Hospital
  • Study coordinator: Murat Aksun, M.D.
  • Email: murataksun@yahoo.com
  • Phone: +90 552 363 16 14

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.